David Krempa insider trades

Open-market stock purchases and sales by David Krempa, Chief Business Officer at Eton Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 13, 2024.

Recent trades

DateStockTradeValue
Jun 26, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
May 27, 2026ETON Eton Pharmaceuticals, IncSold$619K
May 27, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
May 27, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
May 26, 2026ETON Eton Pharmaceuticals, IncSold$1.2M
May 26, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
May 26, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
May 22, 2026ETON Eton Pharmaceuticals, IncSold$1.1M
May 22, 2026ETON Eton Pharmaceuticals, IncSold$316K
May 22, 2026ETON Eton Pharmaceuticals, IncSold$18.2K
May 22, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 14, 2026ETON Eton Pharmaceuticals, IncSold (not open market)$30.3K
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Dec 12, 2025ETON Eton Pharmaceuticals, IncSold (not open market)$106K
Dec 11, 2025ETON Eton Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ETON Eton Pharmaceuticals, Inc: 8 sales, last Jun 26, 2026

Get free alerts when David Krempa files a new trade →